Peripheral arterialization devices and methods of using the same
US-9504781-B2 · Nov 29, 2016 · US
US10736729B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10736729-B2 |
| Application number | US-201615363377-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2016 |
| Priority date | Dec 19, 2008 |
| Publication date | Aug 11, 2020 |
| Grant date | Aug 11, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Peripheral arterialization devices and methods of using the same. In an exemplary embodiment of a catheter for facilitating venous arterialization of the present disclosure, the catheter comprises an elongated body extending from a proximal end to a distal end and having a lumen defined therethrough along a longitudinal length of the elongated body, the elongated body configured to attach to a graft at or near the proximal end of the elongated body and further configured to permit fluid to flow through the graft, through the lumen, and out of one or more apertures defined within the elongated body at or near the distal end to facilitate venous arterialization upon at least partial implantation of the catheter into a vein of a patient.
Opening claim text (preview).
The invention claimed is: 1. A device for facilitating venous arterialization, comprising: a catheter comprising an elongated body extending from a proximal end to a distal end and having a lumen defined therethrough along a longitudinal length of the elongated body; and a graft, wherein the elongated body is configured to attach to the graft at or near the proximal end of the elongated body; wherein the device is configure ed to permit fluid to flow through the graft, through the lumen, and out of one or more apertures defined within the elongated body at or near the distal end to facilitate venous arterialization upon at least partial implantation of the device into a vein of a patient; wherein the catheter further comprises one or more nodes defined along the longitudinal length of the catheter, the one or more nodes configured to at least partially occlude the vein when at least part of the catheter is implanted therein; and wherein a first node of the one or more nodes is located proximal to the one or more apertures and has a first resorption rate, wherein a second node of the one or more nodes is located proximal to the first of the one or more nodes and has a second resorption rate, wherein the first resorption rate is faster than the second resorption rate. 2. The device of claim 1 , wherein the elongated body further comprises a balloon coupled thereto, the balloon operable to inflate and deflate within a vein and further configured to occlude the vein upon inflation. 3. The device of claim 1 , wherein the device is configured so that when at least part of the catheter is implanted into the patient, oxygenated arterial blood is permitted to flow through the graft, through the lumen, and out of the one or more apertures to facilitate peripheral vein arterialization. 4. The device of claim 1 , further comprising a connector coupled to the catheter at or near the proximal end of the catheter, the connector configured to couple to the graft. 5. The device of claim 1 , further comprising an external shaft surrounding at least a portion of the catheter. 6. The device of claim 1 , wherein at least a portion of the catheter is biodegradable or bioresorbable. 7. The device of claim 1 , wherein at least a portion of the catheter comprises a material selected from the group consisting of polytetrafluoroethylene, polyethylene terephthalate, and poly(lactic-co-glycolic acid). 8. The device of claim 1 , wherein at least a portion of the catheter is coated with a material selected from the group consisting of an anticoagulant, an antithrombotic material, and heparin. 9. A peripheral arterialization method, comprising the steps of: positioning a first end of the graft of the device of claim 1 within an artery; positioning the distal end of the catheter into a vein; advancing the distal end to a desired location within the vein; and connecting the second end of the graft to a proximal end of the catheter so to permit blood to flow from the artery, through the graft, through the catheter, and out of one or more of the plurality of apertures into the vein at the desired location; wherein the steps of positioning the first end of the graft within the artery and positioning the distal end of the catheter into the vein are performed in either order. 10. The method of claim 9 , further comprising the step of: positioning the second end of the graft within the vein. 11. The method of claim 9 , further comprising the step of: moving the distal end of the catheter to a second location within the vein after a period of time has elapsed. 12. The method of claim 9 , wherein the method is performed to facilitate arterialization of the vein at or distal to the desired location within the vein. 13. A peripheral arterialization method, comprising the steps of: subcutaneously implanting at least a portion of the catheter of the device of claim 1 into a mammalian patient; positioning the distal end of the catheter into a vein at or near a desired location within the vein; positioning a first end of graft within an artery; and connecting a second end of the graft to the proximal end of the catheter so to permit blood to flow from the artery, through the graft, through the catheter, and out of one or more of the plurality of apertures into the vein at the desired location; wherein the steps of subcutaneously implanting at least a portion of the catheter and positioning the first end of the graft within the artery are performed in either order. 14. The method of claim 13 , wherein the step of subcutaneously implanting at least a portion of the catheter is performed by subcutaneously implanting at least a portion of the catheter parallel to or substantially parallel to the vein. 15. The method of claim 13 , wherein the step of subcutaneously implanting at least a portion of the catheter is performed by introducing and subcutaneously advancing a dilator having a dilator lumen defined therein and a guidewire positioned within the guidewire lumen into the mammalian patient to create a subcutaneous tunnel, removing the dilator, and advancing at least a portion of the catheter within over the guidewire. 16. The method of claim 13 , further comprising the step of: inflating a balloon coupled to the catheter to occlude the vein and to prevent antegrade flow of blood within the vein proximal to the balloon.
for blood vessels · CPC title
End-to-side connections, e.g. T- or Y-connections · CPC title
Arterio-venous shunts or fistulae · CPC title
with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon · CPC title
Interfaces between patient blood circulation and extra-corporal blood circuit · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.